ECHA | Speeding up the supply of disinfectants

Your substances


As the COVID-19 pandemic grows, it is essential for healthcare professionals and European citizens to have access to more disinfectants. To improve this access, there is a need to increase the manufacture and supply of these products.

Companies looking to quickly access the market with their disinfectants that contain an already approved active substance, can apply for permission to the relevant national authority by relying on Article 55(1) of the Biocidal Products Regulation (BPR). This provision allows national authorities to give time-limited derogations from the standard product authorisation requirements in situations where there is a threat to public health.

Several EU/EEA countries have already granted such permissions to companies that have the capacity to manufacture disinfectants. For applications that target several countries, a centralised submission to ECHA is being developed. More information about that will follow in the coming days.



Related News